Nick Loizos - Concepedia

Author

Nick Loizos

Eli Lilly (United States)

Also Known As

N Loizos, N. Loizos, Nick Loizos

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)SciClone Pharmaceuticals (United States)Wadsworth Center New York State Department of Health Albany Medical Center Hospital

About

Nick Loizos is an author at Eli Lilly (United States) specializing in medicine, molecular biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	568
2	Natural Sciences	5	5	271
3	Cell Biology	3	3	108
4	Biology	2	2	116
5	Biomolecular Engineering	1	1	32

Nick Loizos

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target Nick Loizos, Yan Xu, Jim Huber, Molecular Cancer Therapeutics	2005	119
Platelet-derived growth factor receptor-α: a novel therapeutic target in human hepatocellular cancer Peggy Stock, Dulabh Monga, Xinping Tan, Molecular Cancer Therapeutics	2007	107
Lack of detection of agonist activity by antibodies to platelet‐derived growth factor receptor α in a subset of normal and systemic sclerosis patient sera Nick Loizos, Leah M. LaRiccia, Jami Weiner, Arthritis & Rheumatism	2009	82
The td intron endonuclease I-TevI makes extensive sequence-tolerant contacts across the minor groove of its DNA target. Mary Bryk, Susan M. Quirk, John Mueller, The EMBO Journal ChromatinDna SequencingMinor GrooveDna TargetNatural Sciences	1993	75
Evolution of mobile group I introns: recognition of intron sequences by an intron-encoded endonuclease. Nick Loizos, Elisabeth R.M. Tillier, Marlene Belfort Proceedings of the National Academy of Sciences GeneticsGenomic MechanismMolecular BiologyMolecular GeneticsGenomics	1994	66
Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody Juqun Shen, Marie Danielle Vil, Marie Prewett, Neoplasia	2009	63
Rationale for the development of IMC‐3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet‐derived growth factor receptor α Gaurav Shah, Nick Loizos, Hagop Youssoufian, Cancer	2010	61
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors E. Gabriela Chiorean, Christopher Sweeney, Hagop Youssoufian, Cancer Chemotherapy and Pharmacology MedicineImmunologyAdvanced Solid TumorsCancer TreatmentMonoclonal Antibody	2014	61
4 Homing Endonucleases John Mueller, Mary Bryk, Nick Loizos, Cold Spring Harbor Monograph Archive GeneticsGenomic MechanismMolecular BiologyMolecular GeneticsGenomics	1993	50
The td intron endonuclease I-TevI makes extensive sequence-tolerant contacts across the minor groove of its DNA target. Mary Bryk, Susan M. Quirk, John Mueller, The EMBO Journal ChromatinDna SequencingMinor GrooveDna TargetNatural Sciences	1993	48

Page 1